Frankfurt - Delayed Quote EUR
Option Care Health, Inc. (MM6A.F)
27.80
-1.20
(-4.14%)
At close: May 14 at 8:07:08 AM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 9 | 9 | 10 | 10 |
| Avg. Estimate | 1.35B | 1.4B | 5.55B | 6.02B |
| Low Estimate | 1.33B | 1.38B | 5.5B | 5.91B |
| High Estimate | 1.38B | 1.43B | 5.6B | 6.11B |
| Year Ago Sales | 1.23B | 1.28B | 5B | 5.55B |
| Sales Growth (year/est) | 10.25% | 9.54% | 11.01% | 8.52% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| MM6A.F | -- | -- | -- | -- |
| S&P 500 | 13.20% | 2.98% | 8.01% | 13.77% |
Upgrades & Downgrades
| Maintains | Barrington Research: Outperform to Outperform | 4/30/2025 |
| Upgrade | UBS: Neutral to Buy | 4/30/2025 |
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 4/22/2025 |
| Maintains | Barrington Research: Outperform to Outperform | 4/21/2025 |
| Maintains | JP Morgan: Overweight to Overweight | 3/6/2025 |
| Maintains | Barrington Research: Outperform to Outperform | 2/27/2025 |